Anti-CCR9 antibody

MX2026008144APending Publication Date: 2026-10-02SUNROCK BIOPHARMA SL +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MX2026008144
Authority / Receiving Office
MX · MX
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-27
Filing Date
2026-06-26
Publication Date
2026-10-02
Patent Text Reader

Abstract

The present invention provides an anti-CCR9 antibody or antigen binding fragment thereof comprising a variable light chain comprising SEQ ID NO:1 or a variant thereof having at least 95% sequence identity to SEQ ID NO:1, wherein the variable light chain comprises a CDR-L1 comprising the amino acid sequence RSSQSLXHSNGXTFLH (SEQ ID NO: 2), a CDR-L2 comprising the amino acid sequence KVSNRFS (SEQ ID NO: 3) and a CDR-L3 comprising the amino acid sequence SQTTHXPWT (SEQ ID NO: 4), wherein X can be any amino acid. Also provided is the anti-CCR9 antibody or antigen binding fragment thereof for use in the treatment or prevention of a disease, as well as methods of diagnosis and antibody drug conjugates.
Need to check novelty before this filing date? Find Prior Art